Search Results 1261-1270 of 17106 for monoclonal antibody
Monoclonal antibodies =< 2 weeks; Radiation therapy =< 2 weeks; Anti-Her-2 or other "targeted" (e.g. mammalian target of rapamycin [mTOR]) therapy =< 2 weeks.
Monoclonal gammopathy. Nelson Leung, M.D., studies kidney diseases caused by monoclonal ... Schinstock studies therapy for chronic antibody-mediated rejection ...
BCMA targeted antibody-drug conjugate therapy (ADC);; BCMA targeted immune cell engaging antibody (IEA);; Novel target (i.e. GPRC5D) directed CAR T-cell or ...
No prior anti-amyloid monoclonal antibody treatments or therapeutic trials targeting amyloid or tau prior to initiating study. Tracer comparison sub-sample ...
Antibodies as drugs-a Keystone Symposia report. ... Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
... antibody levels observed following Flu-IVIG transfusion are similar to those predicted. This pilot study will inform a larger study that will be powered to ...
The antibodies target unwanted excess proteins, ideally before they can kill nerve cells in the brain, explains researcher and behavioral neurologist David ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.